Women with the famous breast cancer mutations BRCA1 and BRCA 2 who did prophylactic salpingo-oophorectomy (RRSO) followed the use of hormonal replacement therapy showed no effect on the breast cancer risk at least for estrogen formulation alone of hormonal replacement therapy [191]. Here, BRCA1 is linked to breast carcinoma.